Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications

Ben Brannick, Anne Wynn, Samuel Dagogo-Jack

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Prediabetes is a state characterized by impaired fasting glucose or impaired glucose tolerance. Evidence is increasingly demonstrating that prediabetes is a toxic state, in addition to being a harbinger of future development of diabetes mellitus. This minireview discusses the pathophysiology and clinical significance of prediabetes, and approach to its management, in the context of the worldwide diabetes epidemic. The pathophysiologic defects underlying prediabetes include insulin resistance, β cell dysfunction, increased lipolysis, inflammation, suboptimal incretin effect, and possibly hepatic glucose overproduction. Recent studies have revealed that the long-term complications of diabetes may manifest in some people with prediabetes; these complications include classical microvascular and macrovascular disorders, and our discussion explores the role of glycemia in their development. Finally, landmark intervention studies in prediabetes, including lifestyle modification and pharmacologic treatment, are reviewed.

Original languageEnglish (US)
Pages (from-to)1323-1331
Number of pages9
JournalExperimental Biology and Medicine
Volume241
Issue number12
DOIs
StatePublished - Jun 1 2016

Fingerprint

Prediabetic State
Poisons
Medical problems
Glucose
Incretins
Insulin
Defects
Glucose Intolerance
Lipolysis
Diabetes Complications
Insulin Resistance
Life Style
Fasting
Diabetes Mellitus
Inflammation
Liver

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications. / Brannick, Ben; Wynn, Anne; Dagogo-Jack, Samuel.

In: Experimental Biology and Medicine, Vol. 241, No. 12, 01.06.2016, p. 1323-1331.

Research output: Contribution to journalArticle

@article{df9a2c7814e146e99459eb62b906d32e,
title = "Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications",
abstract = "Prediabetes is a state characterized by impaired fasting glucose or impaired glucose tolerance. Evidence is increasingly demonstrating that prediabetes is a toxic state, in addition to being a harbinger of future development of diabetes mellitus. This minireview discusses the pathophysiology and clinical significance of prediabetes, and approach to its management, in the context of the worldwide diabetes epidemic. The pathophysiologic defects underlying prediabetes include insulin resistance, β cell dysfunction, increased lipolysis, inflammation, suboptimal incretin effect, and possibly hepatic glucose overproduction. Recent studies have revealed that the long-term complications of diabetes may manifest in some people with prediabetes; these complications include classical microvascular and macrovascular disorders, and our discussion explores the role of glycemia in their development. Finally, landmark intervention studies in prediabetes, including lifestyle modification and pharmacologic treatment, are reviewed.",
author = "Ben Brannick and Anne Wynn and Samuel Dagogo-Jack",
year = "2016",
month = "6",
day = "1",
doi = "10.1177/1535370216654227",
language = "English (US)",
volume = "241",
pages = "1323--1331",
journal = "Experimental Biology and Medicine",
issn = "1535-3702",
publisher = "SAGE Publications Ltd",
number = "12",

}

TY - JOUR

T1 - Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications

AU - Brannick, Ben

AU - Wynn, Anne

AU - Dagogo-Jack, Samuel

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Prediabetes is a state characterized by impaired fasting glucose or impaired glucose tolerance. Evidence is increasingly demonstrating that prediabetes is a toxic state, in addition to being a harbinger of future development of diabetes mellitus. This minireview discusses the pathophysiology and clinical significance of prediabetes, and approach to its management, in the context of the worldwide diabetes epidemic. The pathophysiologic defects underlying prediabetes include insulin resistance, β cell dysfunction, increased lipolysis, inflammation, suboptimal incretin effect, and possibly hepatic glucose overproduction. Recent studies have revealed that the long-term complications of diabetes may manifest in some people with prediabetes; these complications include classical microvascular and macrovascular disorders, and our discussion explores the role of glycemia in their development. Finally, landmark intervention studies in prediabetes, including lifestyle modification and pharmacologic treatment, are reviewed.

AB - Prediabetes is a state characterized by impaired fasting glucose or impaired glucose tolerance. Evidence is increasingly demonstrating that prediabetes is a toxic state, in addition to being a harbinger of future development of diabetes mellitus. This minireview discusses the pathophysiology and clinical significance of prediabetes, and approach to its management, in the context of the worldwide diabetes epidemic. The pathophysiologic defects underlying prediabetes include insulin resistance, β cell dysfunction, increased lipolysis, inflammation, suboptimal incretin effect, and possibly hepatic glucose overproduction. Recent studies have revealed that the long-term complications of diabetes may manifest in some people with prediabetes; these complications include classical microvascular and macrovascular disorders, and our discussion explores the role of glycemia in their development. Finally, landmark intervention studies in prediabetes, including lifestyle modification and pharmacologic treatment, are reviewed.

UR - http://www.scopus.com/inward/record.url?scp=84975062045&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975062045&partnerID=8YFLogxK

U2 - 10.1177/1535370216654227

DO - 10.1177/1535370216654227

M3 - Article

C2 - 27302176

AN - SCOPUS:84975062045

VL - 241

SP - 1323

EP - 1331

JO - Experimental Biology and Medicine

JF - Experimental Biology and Medicine

SN - 1535-3702

IS - 12

ER -